Masco
MAS
68.87
-1.06
-1.52%
Masco
US · MAS
#1220 by market cap
Listed 1970
68.87
-1.06
-1.52%
Live - 5344 symbols - heartbeat 394s ago
· 2026-10-08 07:11
Pre-market
67.64
-1.79%
After-hours
68.87
0.00%
- Market cap
- 13.58B
- P/E (TTM)i
- 15.83
- P/Bi
- -37.21
- EPSi
- 3.86
- Div yieldi
- 1.83%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on MAS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.95, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.40% YoY
Margins
- Gross margin
- 35.43%
- Operating margin
- 16.57%
- Net margin
- 10.71%
Key ratios & quality
- Enterprise valuei
- 15.93B
- Altman Z-Scorei
- 3.95
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.65B | 6.71B | 7.19B | 8.38B | 8.68B | 7.97B | 7.83B | 7.56B |
| Gross profit | 2.33B | 2.37B | 2.59B | 2.86B | 2.71B | 2.84B | 2.83B | 2.68B |
| Selling & admin expenses | 1.26B | 1.30B | 1.33B | 1.84B | 1.39B | 1.47B | 1.47B | 1.43B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.06B | 1.08B | 1.26B | 1.02B | 1.32B | 1.36B | 1.36B | 1.25B |
| Pretax profit | 907.00M | 914.00M | 1.13B | 688.00M | 1.19B | 1.24B | 1.16B | 1.14B |
| Tax | 221.00M | 230.00M | 269.00M | 210.00M | 288.00M | 278.00M | 287.00M | 277.00M |
| Net profit | 784.00M | 980.00M | 1.28B | 478.00M | 905.00M | 960.00M | 874.00M | 858.00M |
| Basic EPS | 2 | 3 | 5 | 2 | 4 | 4 | 4 | 4 |
| Diluted EPS | 2.37 | 3.22 | 4.59 | 1.62 | 3.63 | 4.02 | 3.76 | 3.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.80B | 2.05B | 1.92B | 1.79B | 1.92B | 1.99B |
| Gross profit | 644.00M | 772.00M | 656.00M | 606.00M | 686.00M | 868.00M |
| Selling & admin expenses | 358.00M | 361.00M | 353.00M | 354.00M | 369.00M | 397.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 286.00M | 411.00M | 303.00M | 252.00M | 317.00M | 471.00M |
| Pretax profit | 254.00M | 378.00M | 276.00M | 227.00M | 291.00M | 440.00M |
| Tax | 56.00M | 95.00M | 76.00M | 51.00M | 63.00M | 107.00M |
| Net profit | 198.00M | 283.00M | 200.00M | 176.00M | 228.00M | 333.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.87 | 1.28 | 0.90 | 0.80 | 1.05 | 1.60 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.77B | 2.71B | 3.49B | 3.42B | 2.95B | 2.86B | 2.73B | 2.84B |
| Cash & ST investments | 552.00M | 697.00M | 1.33B | 926.00M | 452.00M | 634.00M | 634.00M | 647.00M |
| Inventory | 798.00M | 754.00M | 876.00M | 1.22B | 1.24B | 1.02B | 938.00M | 1.05B |
| Total assets | 5.39B | 5.03B | 5.78B | 5.58B | 5.19B | 5.36B | 5.02B | 5.20B |
| Total current liabilities | 1.68B | 1.55B | 1.93B | 1.94B | 1.89B | 1.70B | 1.56B | 1.57B |
| Short-term debt | 8.00M | 40.00M | 42.00M | 48.00M | 244.00M | 47.00M | 46.00M | 49.00M |
| Long-term debt | 2.97B | 2.77B | 2.79B | 2.95B | 2.95B | 2.95B | 2.95B | 2.95B |
| Total liabilities | 5,324,000,000.00 | 5,083,000,000.00 | 5,356,000,000.00 | 5,497,000,000.00 | 5,429,000,000.00 | 5,247,000,000.00 | 5,069,000,000.00 | 5,126,000,000.00 |
| Total equity | 69.00M | -56.00M | 421.00M | 78.00M | -242.00M | 116.00M | -53.00M | 75.00M |
| Retained earnings | -278.00M | -332.00M | 79.00M | -652.00M | -947.00M | -596.00M | -693.00M | -688.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.80B | 2.93B | 2.96B | 2.84B | 2.90B | 3.07B |
| Cash & ST investments | 377.00M | 390.00M | 559.00M | 647.00M | 388.00M | 548.00M |
| Inventory | 1.05B | 1.10B | 1.07B | 1.05B | 1.07B | 1.06B |
| Total assets | 5.11B | 5.29B | 5.31B | 5.20B | 5.23B | 5.40B |
| Total current liabilities | 1.60B | 1.61B | 1.58B | 1.57B | 1.65B | 1.65B |
| Short-term debt | 133.00M | 48.00M | 2.00M | 49.00M | 129.00M | 2.00M |
| Long-term debt | 2.95B | 2.95B | 2.95B | 2.95B | 2.95B | 3.25B |
| Total liabilities | 5,113,000,000.00 | 5,139,000,000.00 | 5,142,000,000.00 | 5,126,000,000.00 | 5,206,000,000.00 | 5,520,000,000.00 |
| Total equity | -6.00M | 149.00M | 169.00M | 75.00M | 27.00M | -119.00M |
| Retained earnings | -693.00M | -583.00M | -576.00M | -688.00M | -722.00M | -849.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.03B | 833.00M | 953.00M | 930.00M | 840.00M | 1.41B | 1.08B | 1.02B |
| Depreciation & amortization | 156.00M | 159.00M | 133.00M | 151.00M | 145.00M | 149.00M | 150.00M | 148.00M |
| Free cash flow | 813.00M | 671.00M | 839.00M | 802.00M | 616.00M | 1.17B | 907.00M | 866.00M |
| Dividends paid | -134.00M | -144.00M | -145.00M | -211.00M | -258.00M | -257.00M | -254.00M | -261.00M |
| Stock buybacks / issuance | -654.00M | -896.00M | -727.00M | -1.03B | -914.00M | -353.00M | -751.00M | -571.00M |
| Ending cash balance | 559.00M | 697.00M | 1.33B | 926.00M | 452.00M | 634.00M | 634.00M | 647.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -158.00M | 306.00M | 456.00M | 418.00M | -79.00M | 496.00M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -190.00M | 270.00M | 415.00M | 371.00M | -113.00M | 453.00M |
| Dividends paid | -66.00M | -66.00M | -65.00M | -64.00M | -65.00M | -64.00M |
| Stock buybacks / issuance | -130.00M | -101.00M | -123.00M | -217.00M | -202.00M | -390.00M |
| Ending cash balance | 377.00M | 390.00M | 559.00M | 647.00M | 388.00M | 548.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | 5,075.00 | -- | -- | -- | -- |
| ROA %i | 13.36 | 17.83 | 22.49 | 7.15 | 15.65 | 17.21 | 15.84 | 15.86 |
| ROIC %i | -- | -- | -- | 19.36 | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.33 | 16.00 | 17.74 | 11.53 | 14.99 | 16.87 | 16.10 | 16.34 |
| FCF / sales %i | 9.73 | 10.00 | 11.67 | 9.58 | 7.10 | 14.69 | 11.59 | 11.45 |
| Current ratioi | 1.64 | 1.75 | 1.80 | 1.76 | 1.56 | 1.68 | 1.75 | 1.81 |
| Quick ratioi | 0.92 | 1.09 | 1.27 | 1.08 | 0.85 | 1.02 | 1.07 | 1.06 |
| Debt / assetsi | 55.24 | 59.14 | 51.64 | 56.84 | 66.42 | 60.62 | 64.08 | 61.82 |
| LT debt / equityi | -- | -- | 1,508.21 | -- | -- | -- | -- | -- |
| Interest coveragei | 7.68 | 6.75 | 8.85 | 3.47 | 12.05 | 12.68 | 12.73 | 12.24 |
| Revenue CAGR (3Y) %i | -2.33 | -3.05 | 6.12 | 7.97 | 8.98 | 3.49 | -2.23 | -4.49 |
| Net income CAGR (3Y) %i | 27.40 | 23.78 | 31.93 | -17.78 | -3.28 | -9.48 | 26.30 | -1.44 |
| FCF CAGR (3Y) %i | 7.63 | 3.28 | 13.23 | -0.45 | -2.81 | 11.72 | 4.19 | 12.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 15.19 | 15.11 | 15.59 | 15.86 | 16.19 | 16.56 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.92 | 16.17 | 16.68 | 16.34 | 16.58 | 17.55 |
| FCF / sales %i | 10.93 | 10.56 | 11.14 | 11.45 | 12.28 | 14.78 |
| Current ratioi | 1.75 | 1.82 | 1.88 | 1.81 | 1.75 | 1.86 |
| Quick ratioi | 1.02 | 1.06 | 1.10 | 1.06 | 1.03 | 1.15 |
| Debt / assetsi | 64.73 | 60.97 | 59.74 | 61.82 | 63.10 | 64.67 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 12.26 | 12.27 | 12.54 | 12.24 | 12.60 | 12.98 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Plumbing Products is the largest reported line at 67.12% of revenue, across 2 reported segments.
- Decorative Architectural Products follows at 32.88%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Plumbing Products67.12%
Decorative Architectural Products32.88%
Quote time 2026-10-08 07:11:04 · For reference only, not investment advice and not tailored to your situation.